Zobrazeno 1 - 10
of 14 374
pro vyhledávání: '"cell renal cell carcinoma"'
Publikováno v:
Biologics: Targets & Therapy, Vol Volume 18, Pp 397-412 (2024)
Lei Yin,1– 3,* Lixin Mao,4,* Rui Yin,5,* Chengxun Lv,1,* Xiaokai Shi,4 Chuang Yue,4 Yin Chen,4 Chao Lu,4 Zonglin Wu,1 Kai Xu,4 Wei Cao4 1Department of Urology, Shidong Hospital, Yangpu District, Shidong Hospital Affiliated to Univer
Externí odkaz:
https://doaj.org/article/c700c5ed72f94feeac758106728627f3
Autor:
Jie Wen, Yi Rong, Yinbo Kang, Dingyang Lv, Fan Cui, Huiyu Zhou, Mohan Jia, Qiwei Wang, Weibing Shuang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Clear cell renal cell carcinoma (ccRCC) and ischemic stroke are critical global health challenges with a notable association. This study explores the correlation between tumor-related factors and ischemic stroke risk, aiming to construct a p
Externí odkaz:
https://doaj.org/article/b4c6558f53034720b175afa7f55722b5
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-26 (2024)
Abstract Background Clear cell renal cell carcinoma (ccRCC) tumours develop and progress via complex remodelling of the kidney epigenome, transcriptome, proteome and metabolome. Given the subsequent tumour and inter-patient heterogeneity, drug-based
Externí odkaz:
https://doaj.org/article/c0ffeed62cb74c2e87e0394d0b82398f
Autor:
Honglei Cui, Jie Wu, Gan Du, Linjun Hu, Xin Dong, Wang Qu, Hongsong Bai, Bingqing Shang, Ruiyang Xie, Hongzhe Shi, Youyan Guan, Xingang Bi, Changling Li, Jianhui Ma, Aiping Zhou, Jianzhong Shou
Publikováno v:
European Urology Open Science, Vol 70, Iss , Pp 109-115 (2024)
Background and objective: Systemic treatments involving immunotherapy-tyrosine kinase inhibitor (IO-TKI) combinations and TKI monotherapy have significantly improved outcomes for patients with metastatic clear-cell renal cell carcinoma (mccRCC). Howe
Externí odkaz:
https://doaj.org/article/ca4092eed5c54da7afd430d2cda674b6
Autor:
Yun Han, Guanyun Wang, Jingfeng Zhang, Yue Pan, Jianbo Cui, Can Li, Yanmei Wang, Xiaodan Xu, Baixuan Xu
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Background The aim is to develop and validate radiomics based on 2-[18F]fluoro-D-glucose positron emission tomography/computed tomography (2-[18F]FDG PET/CT) parameters for predicting the World Health Organization/International Society of Ur
Externí odkaz:
https://doaj.org/article/7b707102b26d4751a5173f91104a78ff
Publikováno v:
Open Life Sciences, Vol 19, Iss 1, Pp 12-49 (2024)
Clear cell renal cell carcinoma (ccRCC) is a challenging malignancy characterized by intricate biology and clinical characteristics. Despite advancements in treatment strategies, the molecular mechanisms underlying ccRCC initiation, progression, and
Externí odkaz:
https://doaj.org/article/fa648a50752e49fa899f77f0b6394888
Publikováno v:
BioData Mining, Vol 17, Iss 1, Pp 1-23 (2024)
Abstract Background Regulatory T cells (Tregs) play a critical role in shaping the immunosuppressive microenvironment within tumors. Investigating the role of Tregs in Clear cell renal cell carcinoma (ccRCC) is crucial for identifying prognostic mark
Externí odkaz:
https://doaj.org/article/2598e4ce41124f45a490be946866104e
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background This study aims to construct predicting models using radiomic and clinical features in predicting first-line vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFR-TKI) early resistance in metastatic clear ce
Externí odkaz:
https://doaj.org/article/f15aae7cc7074e028a54a4998fad7b67
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Clear cell renal cell carcinoma (ccRCC) is a common genitourinary malignancy characterized by dysregulated cellular metabolism leading to aberrant glucose metabolism, fatty acid accumulation, and excessive reactive oxygen species production.
Externí odkaz:
https://doaj.org/article/f7948f82d5f249858d1936668acadcc4
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract The crosstalk between cuproptosis and the tumor immune microenvironment (TIME) is vital during clear cell renal cell carcinoma (ccRCC) malignant progression. However, the underlying molecular mechanisms regulate this cross-talk remain elusiv
Externí odkaz:
https://doaj.org/article/dbf8cba2922e4f1f80748e2b0e458c90